|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson DE, Burtness B, Leemans CR, Lui
VWY, Bauman JE and Grandis JR: Head and neck squamous cell
carcinoma. Nat Rev Dis Prim. 6:922020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferlito A, Silver CE, Bradford CR and
Rinaldo A: Neuroendocrine neoplasms of the larynx: An overview.
Head Neck. 31:1634–1646. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hunt JL, Barnes L, Triantafyllou A, Gnepp
DR, Devaney KO, Stenman G, Halmos GB, Bishop JA, Skálová A, Willems
SM, et al: Well-differentiated neuroendocrine carcinoma of the
larynx: Confusion of terminology and uncertainty of early studies.
Adv Anat Pathol. 26:246–250. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Machiels JP, René Leemans C, Golusinski W,
Grau C, Licitra L and Gregoire V; EHNS Executive Board, ESMO
Guidelines Committee and ESTRO Executive Board, : Reprint of
‘Squamous cell carcinoma of the oral cavity, larynx, oropharynx and
hypopharynx: EHNS-ESMO-ESTRO clinical practice guidelines for
diagnosis, treatment and follow-up’. Oral Oncol. 113:1050422021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Forastiere AA, Ismaila N, Lewin JS, Nathan
CA, Adelstein DJ, Eisbruch A, Fass G, Fisher SG, Laurie SA, Le QT,
et al: Use of larynx-preservation strategies in the treatment of
laryngeal cancer: American society of clinical oncology clinical
practice guideline update. J Clin Oncol. 36:1143–1169. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Portela-Gomes GM, Grimelius L, Wilander E
and Stridsberg M: Granins and granin-related peptides in
neuroendocrine tumours. Regul Pept. 165:12–20. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartolomucci A, Possenti R, Mahata SK,
Fischer-Colbrie R, Loh YP and Salton SRJ: The extended granin
family: Structure, function, and biomedical implications. Endocr
Rev. 32:755–797. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Komiya A, Suzuki H, Imamoto T, Kamiya N,
Nihei N, Naya Y, Ichikawa T and Fuse H: Neuroendocrine
differentiation in the progression of prostate cancer. Int J Urol.
16:37–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Massironi S, Conte D, Sciola V, Spampatti
MP, Ciafardini C, Valenti L, Rossi RE and Peracchi M: Plasma
chromogranin A response to octreotide test: Prognostic value for
clinical outcome in endocrine digestive tumors. Am J Gastroenterol.
105:2072–2078. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kusafuka K, Abe M, Iida Y, Onitsuka T,
Fuke T, Asano R, Kamijo T and Nakajima T: Mucosal large cell
neuroendocrine carcinoma of the head and neck regions in Japanese
patients: A distinct clinicopathological entity. J Clin Pathol.
65:704–709. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lewis JS Jr, Chernock RD and Bishop JA:
Squamous and neuroendocrine specific immunohistochemical markers in
head and neck squamous cell carcinoma: A tissue microarray study.
Head Neck Pathol. 12:62–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang KR, Jia YJ, Zhou SH, Wang QY, Bao YY,
Feng ZY, Yao HT and Fan J: Cutaneous and subcutaneous metastases
from atypical laryngeal carcinoids: Case report and review of the
literature. Medicine (Baltimore). 95:e27962016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salton SR, Ferri GL, Hahm S, Snyder SE,
Wilson AJ, Possenti R and Levi A: VGF: A novel role for this
neuronal and neuroendocrine polypeptide in the regulation of energy
balance. Front Neuroendocrinol. 21:199–219. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartolomucci A, La Corte G, Possenti R,
Locatelli V, Rigamonti AE, Torsello A, Bresciani E, Bulgarelli I,
Rizzi R, Pavone F, et al: TLQP-21, a VGF-derived peptide, increases
energy expenditure and prevents the early phase of diet-induced
obesity. Proc Natl Acad Sci USA. 103:14584–14589. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Severini C, Ciotti MT, Biondini L,
Quaresima S, Rinaldi AM, Levi A, Frank C and Possenti R: TLQP-21, a
neuroendocrine VGF-derived peptide, prevents cerebellar granule
cells death induced by serum and potassium deprivation. J
Neurochem. 104:534–544. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shimazawa M, Tanaka H, Ito Y, Morimoto N,
Tsuruma K, Kadokura M, Tamura S, Inoue T, Yamada M, Takahashi H, et
al: An inducer of VGF protects cells against ER stress-induced cell
death and prolongs survival in the mutant SOD1 animal models of
familial ALS. PLoS One. 5:e153072010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Qin X, Han Y and Li B: VGF: A
prospective biomarker and therapeutic target for neuroendocrine and
nervous system disorders. Biomed Pharmacother. 151:1130992022.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Annaratone L, Medico E, Rangel N,
Castellano I, Marchiò C, Sapino A and Bussolati G: Search for
neuro-endocrine markers (chromogranin A, synaptophysin and VGF) in
breast cancers. An integrated approach using immunohistochemistry
and gene expression profiling. Endocr Pathol. 25:219–228. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsumoto T, Kawashima Y, Nagashio R,
Kageyama T, Kodera Y, Jiang SX, Okayasu I, Kameya T and Sato Y: A
new possible lung cancer marker: VGF detection from the conditioned
medium of pulmonary large cell neuroendocrine carcinoma-derived
cells using secretome analysis. Int J Biol Markers. 24:282–285.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ostrow KL, Park HL, Hoque MO, Kim MS, Liu
J, Argani P, Westra W, Van Criekinge W and Sidransky D:
Pharmacologic unmasking of epigenetically silenced genes in breast
cancer. Clin Cancer Res. 15:1184–1191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brait M, Maldonado L, Begum S, Loyo M,
Wehle D, Tavora FF, Looijenga LHJ, Kowalski J, Zhang Z, Rosenbaum
E, et al: DNA methylation profiles delineate epigenetic
heterogeneity in seminoma and non-seminoma. Br J Cancer.
106:414–423. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brait M, Maldonado L, Noordhuis M, Begum
S, Loyo M, Poeta ML, Barbosa A, Fazio VM, Angioli R, Rabitti C, et
al: Association of promoter methylation of VGF and PGP9.5 with
ovarian cancer progression. PLoS One. 8:e708782013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nehar D, Lombard-Bohas C, Olivieri S,
Claustrat B, Chayvialle JA, Penes MC, Sassolas G and Borson-Chazot
F: Interest of chromogranin A for diagnosis and follow-up of
endocrine tumours. Clin Endocrinol (Oxf). 60:644–652. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gabanella F, Colizza A, Mottola MC,
Francati S, Blaconà G, Petrella C, Barbato C, Greco A, Ralli M,
Fiore M, et al: The RNA-binding protein SMN as a novel player in
laryngeal squamous cell carcinoma. Int J Mol Sci. 24:17942023.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou J, Tao D, Xu Q, Gao Z and Tang D:
Expression of E-cadherin and vimentin in oral squamous cell
carcinoma. Int J Clin Exp Pathol. 8:3150–3154. 2015.PubMed/NCBI
|
|
30
|
Busse S, Steiner J, Micheel J, Dobrowolny
H, Mawrin C, Krause TJ, Adamaszek M, Bogerts B, Bommhardt U, Hartig
R and Busse M: Age-related increase of VGF-expression in T
lymphocytes. Aging (Albany NY). 6:440–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Busse S, Steiner J, Glorius S, Dobrowolny
H, Greiner-Bohl S, Mawrin C, Bommhardt U, Hartig R, Bogerts B and
Busse M: VGF expression by T lymphocytes in patients with
Alzheimer's disease. Oncotarget. 6:14843–14851. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Trani E, Giorgi A, Canu N, Amadoro G,
Rinaldi AM, Halban PA, Ferri GL, Possenti R, Schininà ME and Levi
A: Isolation and characterization of VGF peptides in rat brain.
Role of PC1/3 and PC2 in the maturation of VGF precursor. J
Neurochem. 81:565–574. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ferri GL, Noli B, Brancia C, D'Amato F and
Cocco C: VGF: An inducible gene product, precursor of a diverse
array of neuro-endocrine peptides and tissue-specific disease
biomarkers. J Chem Neuroanat. 42:249–261. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bartolomucci A, Possenti R, Levi A, Pavone
F and Moles A: The role of the vgf gene and VGF-derived peptides in
nutrition and metabolism. Genes Nutr. 2:169–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rindi G, Licini L, Necchi V, Bottarelli L,
Campanini N, Azzoni C, Favret M, Giordano G, D'Amato F, Brancia C,
et al: Peptide products of the neurotrophin-inducible gene vgf are
produced in human neuroendocrine cells from early development and
increase in hyperplasia and neoplasia. J Clin Endocrinol Metab.
92:2811–2815. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hwang W, Chiu YF, Kuo MH, Lee KL, Lee AC,
Yu CC, Chang JL, Huang WC, Hsiao SH, Lin SE and Chou YT: Expression
of neuroendocrine factor VGF in lung cancer cells confers
resistance to EGFR kinase inhibitors and triggers
epithelial-to-mesenchymal transition. Cancer Res. 77:3013–3026.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hahm S, Mizuno TM, Wu TJ, Wisor JP, Priest
CA, Kozak CA, Boozer CN, Peng B, McEvoy RC, Good P, et al: Targeted
deletion of the Vgf gene indicates that the encoded secretory
peptide precursor plays a novel role in the regulation of energy
balance. Neuron. 23:537–548. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu A and Curran MA: Tumor hypermetabolism
confers resistance to immunotherapy. Semin Cancer Biol. 65:155–163.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chang CH, Qiu J, O'Sullivan D, Buck MD,
Noguchi T, Curtis JD, Chen Q, Gindin M, Gubin MM, van der Windt GJ,
et al: Metabolic competition in the tumor microenvironment is a
driver of cancer progression. Cell. 162:1229–1241. 2015. View Article : Google Scholar : PubMed/NCBI
|
